How would you label the current system of pharmaceutical pricing in the United States? Efficient? Value pricing? Extreme value pricing? Welfare enhancing? or a Shameful exploitation? In a so called “free market” of a free country, why is it that the pharmaceutical industry is treated like a fragile little bird by the U.S. government? While the government was busy protecting its delicate little bird, it has failed to notice its little sparrow is actually a Crowned Eagle, the most powerful bird of prey! The Trump administration, despite earlier promises, now seems willing to continue that government protection. Read more here. (Source: Uwe Reinhardt, The Health Care Blog, 2/8/17)
You are here: / / How do You Feel About the Sahara Model of Value-Pricing?